Menu Back to Keynote-Speaker

DIA is Proud to Announce the Keynote Speaker for DIA 2018!

Nora D. Volkow, MD, Director, National Institute on Drug Abuse (NIDA), NIH

Monday, June 25 | 8:30-10:00AM

Every day, more than 115 Americans die after overdosing on opioids. The misuse of and addiction to opioids—including prescription pain relievers, heroin, and synthetic opioids such as fentanyl—is a serious national crisis that affects public health as well as social and economic welfare. The Centers for Disease Control and Prevention estimates that the total "economic burden" of prescription opioid misuse alone in the United States is $78.5 billion a year, including the costs of healthcare, lost productivity, addiction treatment, and criminal justice involvement.  
 

Yet the need for pain management therapies is great. More than 25 million Americans suffer from chronic pain and are in need of therapies to manage it. As the Director of the National Institute on Drug Abuse (NIDA) at NIH, Dr. Nora Volkow will present her vision for therapeutics and devices in pain modulation and opioid addiction, with a focus on developing better overdose-reversal and prevention interventions to reduce mortality, saving lives for future treatment and recovery; finding new, innovative medications and technologies to treat opioid addiction; and finding safe, effective, non-addictive interventions to manage chronic pain. Public-private partnerships will play a key role in meeting these challenges through the development of new technologies, regulatory science, and exploratory basic research. 

Dr. Volkow will discuss the need for development of new molecules and formulations, technologies for stimulation of the brain and neurocircuitry, advances in biofeedback, and unique opportunities for wireless and mobile technologies to assist in pain management. She will also emphasize the importance of public-private partnerships in addressing these issues and how to get involved.